Jamieson Wellness Inc.
TSX:JWEL.TO
33.03 (CAD) • At close September 13, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) CAD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 676.172 | 547.369 | 451.032 | 403.661 | 344.98 | 319.776 | 300.619 | 248.331 | 230.865 | 193.218 |
| Cost of Revenue
| 442.613 | 349.031 | 288.591 | 258.905 | 215.246 | 204.358 | 195.77 | 167.519 | 152.966 | 141.565 |
| Gross Profit
| 233.559 | 198.338 | 162.441 | 144.756 | 129.734 | 115.418 | 104.849 | 80.812 | 77.899 | 51.653 |
| Gross Profit Ratio
| 0.345 | 0.362 | 0.36 | 0.359 | 0.376 | 0.361 | 0.349 | 0.325 | 0.337 | 0.267 |
| Reseach & Development Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 146.172 | 115.149 | 86.411 | 81.184 | 74.285 | 66.289 | 59.914 | 49.771 | 52.372 | 40.965 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 146.172 | 115.149 | 86.411 | 81.184 | 74.285 | 66.289 | 59.914 | 49.771 | 52.372 | 40.965 |
| Other Expenses
| -4.833 | 0 | 0 | -0.022 | 0.022 | -0.403 | -29.779 | -27.558 | -94.054 | -14.98 |
| Operating Expenses
| 146.172 | 115.149 | 86.411 | 81.184 | 74.285 | 66.289 | 59.914 | 49.771 | 52.372 | 40.965 |
| Operating Income
| 95.25 | 83.189 | 76.03 | 63.572 | 55.449 | 50.09 | 44.935 | 31.041 | 25.527 | 10.688 |
| Operating Income Ratio
| 0.141 | 0.152 | 0.169 | 0.157 | 0.161 | 0.157 | 0.149 | 0.125 | 0.111 | 0.055 |
| Total Other Income Expenses Net
| 65.671 | -12.686 | -5.565 | -6.524 | -13.145 | -2.878 | -45.113 | -29.575 | -95.098 | -25.246 |
| Income Before Tax
| 65.671 | 70.503 | 70.465 | 57.048 | 42.304 | 37.251 | -15.631 | -21.46 | -93.438 | -36.362 |
| Income Before Tax Ratio
| 0.097 | 0.129 | 0.156 | 0.141 | 0.123 | 0.116 | -0.052 | -0.086 | -0.405 | -0.188 |
| Income Tax Expense
| 19.631 | 17.695 | 18.383 | 15.45 | 10.647 | 10.578 | 8.156 | 3.706 | 1.944 | -3.186 |
| Net Income
| 47.882 | 52.808 | 52.082 | 41.598 | 31.657 | 26.673 | -23.787 | -25.166 | -95.382 | -33.176 |
| Net Income Ratio
| 0.071 | 0.096 | 0.115 | 0.103 | 0.092 | 0.083 | -0.079 | -0.101 | -0.413 | -0.172 |
| EPS
| 1.14 | 1.29 | 1.3 | 1.05 | 0.82 | 0.7 | -1.28 | -0.67 | -2.53 | -0.88 |
| EPS Diluted
| 1.12 | 1.25 | 1.25 | 1.01 | 0.8 | 0.67 | -1.27 | -0.67 | -2.53 | -0.88 |
| EBITDA
| 102.877 | 100.437 | 90.304 | 75.759 | 61.919 | 56.319 | 8.448 | 10.062 | -62.234 | 1.332 |
| EBITDA Ratio
| 0.152 | 0.183 | 0.2 | 0.188 | 0.179 | 0.176 | 0.028 | 0.041 | -0.27 | 0.007 |